Cargo Therapeutics, Common Stock Today
| CRGX Stock | 15.73 0.09 0.57% |
Performance0 of 100
| Odds Of DistressLess than 25
|
CARGO Therapeutics, is trading at 15.73 as of the 21st of November 2024; that is 0.57 percent decrease since the beginning of the trading day. The stock's open price was 15.82. CARGO Therapeutics, has about a 25 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for CARGO Therapeutics, Common are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 10th of November 2023 | Category Healthcare | Classification Health Care |
CARGO Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 46.03 M outstanding shares of which 5.57 M shares are currently shorted by private and institutional investors with about 31.64 trading days to cover. More on CARGO Therapeutics, Common
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
CARGO Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Gina Chapman | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
| CARGO Therapeutics, can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand CARGO Therapeutics,'s financial leverage. It provides some insight into what part of CARGO Therapeutics,'s total assets is financed by creditors. | ||||||||||||||||||||||||||||||||||||||||||||||
CARGO Therapeutics, Common (CRGX) is traded on NASDAQ Exchange in USA. It is located in 1900 Alameda De Las Pulgas, San Mateo, CA, United States, 94403 and employs 170 people. CARGO Therapeutics, is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 728.16 M. CARGO Therapeutics, conducts business under Biotechnology sector and is part of Health Care industry. The entity has 46.03 M outstanding shares of which 5.57 M shares are currently shorted by private and institutional investors with about 31.64 trading days to cover.
CARGO Therapeutics, generates negative cash flow from operations
Check CARGO Therapeutics, Probability Of Bankruptcy
Ownership AllocationThe majority of CARGO Therapeutics, Common outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CARGO Therapeutics, to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in CARGO Therapeutics,. Please pay attention to any change in the institutional holdings of CARGO Therapeutics, Common as this could imply that something significant has changed or is about to change at the company.
Check CARGO Ownership Details
CARGO Therapeutics, Historical Income Statement
CARGO Stock Against Markets
CARGO Therapeutics, Corporate Management
| JD Esq | Chief Officer | Profile | |
| Ginna MD | Chief Officer | Profile | |
| Faisal MBA | Senior Accounting | Profile | |
| Michael Ports | Chief Officer | Profile |
Additional Tools for CARGO Stock Analysis
When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.